MODIFICATION OF ACL ADVANCE— 510(k) K002400

Name: FDA 510(k) clearance K002400
Creator: U.S. Food and Drug Administration
Published: 2000-08-30

Substantially Equivalent

Instrumentation Laboratory CO

FDA 510(k) clearance K002400 for MODIFICATION OF ACL ADVANCE, Substantially Equivalent on 2000-08-30. Applicant: Instrumentation Laboratory CO. Device class: 2.

Clearance details

Applicant: Instrumentation Laboratory CO
Product code: Code JPA
Device class: Class 2
Regulation: 21 CFR 864.5425
Advisory panel: Hematology
Date received: 2000-08-04
Decision date: 2000-08-30
Decision: Substantially Equivalent
Clearance type: Special
Location: Bedford, MA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JPA

view all

K253658 — STA Satellite Max®2026-04-27
K250965 — Automated Blood Coagulation Analyzer CN-Series (CN-6000)2025-06-02
K251024 — TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge2025-04-30
K243858 — TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge2025-01-15
K232018 — Citrated: K, KH, RTH, FFH2024-03-29

More clearances from Instrumentation Laboratory CO

view all

K221359 — ACL TOP 970 CL, HemosIL CL Anti-Cardiolipin IgM, HemosIL CL Anti-ß2 Glycoprotein-I IgM2023-09-29
K223187 — HemosIL Liquid Anti-Xa2023-06-23
K223090 — GEM Premier ChemSTAT2023-01-27
K223402 — HemosIL von Willebrand Factor Antigen2022-12-09
K213464 — HemosIL Liquid Anti-Xa2022-10-04

Adverse events under product code JPA

product code JPA

Death: 6
Total: 6

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.